专利号:US-5762918-A 优先权日:1992-03-23 标题:Methods of using steroid-polyanionic polymer-based conjugated targeted to vascular endothelial cells 发明人:THORPE PHILIP E 权利人:UNIV TEXAS 摘要:This invention discloses new targeted conjugates for the delivery of a compound, and particularly, a steroid, to vascular endothelial cells. The conjugates comprise two components, preferably linked by a selectively-hydrolyzable bond, such as an acid-labile bond or enzyme-sensitive bond. The first component, a polyanionic polymer, and preferably, a polysulphated polymer such as a heparin-derivative, specifically directs the conjugate to vascular endothelial cells. The second component is a selected agent, such as a steroid, which exerts a specific effect on the target cell following its release. In particular, the present invention provides novel conjugated angiogenesis inhibitors, for use in the treatment of pathogenic conditions including cancer, arthritis, and diabetic blindness. An inhibitor comprising a heparin derivative and the anti-angiogenic steroid, cortisol, is herein shown to be markedly acid-labile, to suppress DNA synthesis and cell migration in human umbilical vein endothelial cells, to retard or abolish (depending pending on the route of injection) the vascularization of sponges in vivo and to retard lung tumor growth in mice by 65%. No adverse effects of the conjugate were detected, and equivalent treatments with a mixture of heparin plus cortisol were significantly less effective in all cases.
1: Liu L, Chen C, Li Y, Ao D, Wu J, Cai N, Li W, Xiang M. Dynamics alteration of the gut microbiota and faecal metabolomes in very low or extremely low birth weight infants: a Chinese single-center, prospective cohort study. Front Microbiol. 2024 Aug 23;15:1438213. doi: 10.3389/fmicb.2024.1438213. 2: Wang F, Xiong NX, Ou J, Zhong ZR, Xie Q, Huang JF, Li KX, Huang MZ, Fang ZX, Kuang XY, Qin ZL, Luo SW. Immunometabolic interplay in Edwardsiella tarda- infected crucian carp (Carassius auratus) and in vitro identification of the antimicrobial activity of apolipoprotein D (ApoD) by utilization of multiomics analyses. Int J Biol Macromol. 2024 Oct;278(Pt 3):134898. doi: 10.1016/j.ijbiomac.2024.134898. Epub 2024 Aug 22. 61(11):9302-9319. doi: 10.1007/s12035-024-04144-1. Epub 2024 Apr 16. 348:123839. doi: 10.1016/j.envpol.2024.123839. Epub 2024 Mar 22. 110(4):808-818. doi: 10.1093/biolre/ioad175.